Towards personalized tumor markers

Area of Science:

• Oncology
• Biomarker Research
• Genomics

Background:

• Cancer biomarker discovery faces slow progress and challenges in finding sensitive and specific markers.
• Tumor genetic heterogeneity complicates the identification of universal cancer biomarkers.
• Existing biomarkers often exhibit high specificity but low sensitivity.

Purpose of the Study:

• To propose a novel approach for improving cancer biomarker research.
• To leverage "rare tumor markers" for personalized cancer diagnosis and management.
• To explore the link between specific genomic alterations and biomarker expression.

Main Methods:

• Identifying biomarkers with high specificity (>90%) and low sensitivity (<30%), termed "rare tumor markers."
• Advocating for broad screening of patients against numerous biomarkers.
• Applying principles of precision medicine to biomarker selection.

Main Results:

• Suggests that "rare tumor markers" may be clinically useful for specific patient subgroups.
• Proposes that broad biomarker screening can identify informative markers for individual patients.
• Hypothesizes that specific genomic alterations underlie the differential expression of these markers.

Conclusions:

• A precision medicine approach, screening for numerous "rare tumor markers," can enhance cancer biomarker utility.
• This strategy aligns with genomic approaches for personalized cancer therapy.
• Further research should investigate the genomic basis of "rare tumor marker" expression.